Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis

Frontiers in Immunology

Volumn 3, Issue APR, 2012, Pages

  Ueha, Satoshi ^a,b   Shand, Francis H W ^a,c   Matsushima, Kouji ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chemokine, tgfb; Collagen I; Fibroblast; Fibrosis; Mesenchymal stem cell; Myofibroblast; Pericyte

Indexed keywords

EID: 84869027272     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00071     Document Type: Short Survey

References (61)

1. Atzori, L., Poli, G., and Perra, A. (2009). Hepatic stellate cell: a star cell in the liver. Int. J. Biochem. Cell Biol. 41, 1639-1642.
2. Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., and Cerami, A. (1994). Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1, 71-81.
3. Campbell, S. E., and Katwa, L. C. (1997). Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofi- broblasts. J. Mol. Cell. Cardiol. 29, 1947-1958.
4. Chambers, R. C., and Laurent, G. J. (2002). Coagulation cascade proteases and tissue fibrosis. Biochem. Soc. Trans. 30, 194-200.
5. Douglass, A., Wallace, K., Parr, R., Park, J., Durward, E., Broadbent, I., Barelle, C., Porter, A. J., and Wright, M. C. (2008). Antibody- targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. J. Hepatol. 49, 88-98.
6. Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., and Iredale, J. P. (2005). Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56-65.
7. Esteban, V., Lorenzo, O., Ruperez, M., Suzuki, Y., Mezzano, S., Blanco, J., Kretzler, M., Sugaya, T., Egido, J., and Ruiz-Ortega, M. (2004). Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15, 1514-1529.
8. Gabbiani, G. (2003). The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500-503.
9. Gabbiani, G., Ryan, G. B., and Majne, G. (1971). Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27, 549-550.
10. Gao, X., He, X., Luo, B., Peng, L., Lin, J., and Zuo, Z. (2009). Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Eur. J. Pharmacol. 606, 115-120.
11. Goritz, C., Dias, D. O., Tomilin, N., Barbacid, M., Shupliakov, O., and Frisen, J. (2011). A pericyte origin of spinal cord scar tissue. Science 333, 238-242.
12. Grone, H. J., Weber, K., Grone, E., Helmchen, U., and Osborn, M. (1987). Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am. J. Pathol. 129, 1-8.
13. Hemmann, S., Graf, J., Roderfeld, M., and Roeb, E. (2007). Expression of MMPs and TIMPs in liver fibrosis-asystematicreviewwithspecial emphasis on anti-fibrotic strategies. J. Hepatol. 46, 955-975.
14. Henderson, W. R. Jr., Chi, E. Y., Ye, X., Nguyen, C., Tien, Y. T., Zhou, B., Borok, Z., Knight, D. A., and Kahn, M. (2010). Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc. Natl. Acad. Sci. U.S.A. 107, 14309-14314.
15. Higashiyama, R., Moro, T., Nakao, S., Mikami, K., Fukumitsu, H., Ueda, Y., Ikeda, K., Adachi, E., Bou-Gharios, G., Okazaki, I., and Inagaki, Y. (2009). Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 137, 1459-1466 e1451.
16. Higashiyama, R., Nakao, S., Shibusawa, Y., Ishikawa, O., Moro, T., Mikami, K., Fukumitsu, H., Ueda, Y., Minakawa, K., Tabata, Y., BouGharios, G., and Inagaki, Y. (2011). Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice. J. Invest. Dermatol. 131, 529-536.
17. Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M. L., and Gabbiani, G. (2007). The myofibroblast: one function, multiple origins. Am. J. Pathol. 170, 1807-1816.
18. Humphreys, B. D., Lin, S. L., Kobayashi, A., Hudson, T. E., Nowlin, B. T., Bonventre, J. V., Valerius, M. T., McMahon, A. P., and Duffield, J. S. (2010). Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85-97.
19. Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Bierie, B., Tada, M., Mohri, D., Miyabayashi, K., Asaoka, Y., Maeda, S., Ikenoue, T., Tateishi, K., Wright, C. V., Koike, K., Omata, M., and Moses, H. L. (2011). Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J. Clin. Invest. 121, 4106-4117.
20. Ishida, Y., Kimura, A., Kondo, T., Hayashi, T., Ueno, M., Takakura, N., Matsushima, K., and Mukaida, N. (2007). Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin- induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am. J. Pathol. 170, 843-854.
21. Kalluri, R., and Neilson, E. G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776-1784.
22. Keeley, E. C., Mehrad, B., and Strieter, R. M. (2011). The role of fibrocytes in fibrotic diseases of the lungs and heart. Fibrogenesis Tissue Repair 4, 2.
23. Kis, K., Liu, X., and Hagood, J. S. (2011). Myofibroblast differentiation and survival in fibrotic disease. Expert Rev. Mol. Med. 13, e27.
24. Kohyama, T., Ertl, R. F., Valenti, V., Spurzem, J., Kawamoto, M., Nakamura, Y., Veys, T., Allegra, L., Romberger, D., and Rennard, S. I. (2001). Prostaglandin E(2) inhibits fibroblast chemotaxis. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L1257-L1263.
25. Konigshoff, M., and Eickelberg, O. (2010). WNT signaling in lung disease: a failure or a regeneration signal? Am. J. Respir. Cell Mol. Biol. 42, 21-31.
26. Kriz, W., Kaissling, B., and Le Hir, M. (2011). Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J. Clin. Invest. 121, 468-474.
27. Lama, V., Moore, B. B., Christensen, P., Toews, G. B., and Peters-Golden, M. (2002). Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am. J. Respir. Cell Mol. Biol. 27, 752-758.
28. Leask, A. (2010). Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 106, 1675-1680.
29. Lee, C. H., Shah, B., Moioli, E. K., and Mao, J. J. (2010). CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J. Clin. Invest. 120, 3340-3349.
30. Lin, S. L., Kisseleva, T., Brenner, D. A., and Duffield, J. S. (2008). Pericytes and perivascular fibroblasts are the primary source of collagen- producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1627.
31. Lo Re, S., Lecocq, M., Uwambayinema, F., Yakoub, Y., Delos, M., Demoulin, J. B., Lucas, S., Sparwasser, T., Renauld, J. C., Lison, D., and Huaux, F. (2011). PDGF-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. Am. J. Respir. Crit. Care Med. 184, 1270-1281.
32. Luzina, I. G., Todd, N. W., Iacono, A. T., and Atamas, S. P. (2008). Roles of T lymphocytes in pulmonary fibrosis. J. Leukoc. Biol. 83, 237-244.
33. Mortaz, E., Folkerts, G., Nijkamp, F. P., and Henricks, P. A. (2010). ATP and the pathogenesis of COPD. Eur. J. Pharmacol. 638, 1-4.
34. Oga, T., Matsuoka, T., Yao, C., Nonomura, K., Kitaoka, S., Sakata, D., Kita, Y., Tanizawa, K., Taguchi, Y., Chin, K., Mishima, M., Shimizu, T., and Narumiya, S. (2009). Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat. Med. 15, 1426-1430.
35. Olaso, E., Arteta, B., Benedicto, A., Crende, O., and Friedman, S. L. (2011). Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages. Am. J. Pathol. 179, 2894-2904.
36. Pattanaik, D., and Postlethwaite, A. E. (2010). A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis. Discov. Med. 10, 161-167.
37. Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., and Strieter, R. M. (2004). Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438-446.
38. Ponticos, M., Holmes, A. M., Shi-wen, X., Leoni, P., Khan, K., Rajkumar, V. S., Hoyles, R. K., Bou-Gharios, G., Black, C. M., Denton, C. P., Abraham, D. J., Leask, A., and Lindahl, G. E. (2009). Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum. 60, 2142-2155.
39. Qi, W., Twigg, S., Chen, X., Polhill, T. S., Poronnik, P., Gilbert, R. E., and Pollock, C. A. (2005). Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. Am. J. Physiol. Renal Physiol. 288, F800-F809.
40. Ricardo, S. D., van Goor, H., and Eddy, A. A. (2008). Macrophage diversity in renal injury and repair. J. Clin. Invest. 118, 3522-3530.
41. Rider, C. C., and Mulloy, B. (2010). Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochem. J. 429, 1-12.
42. Ruperez, M., Lorenzo, O., Blanco-Colio, L. M., Esteban, V., Egido, J., and Ruiz-Ortega, M. (2003). Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 108, 1499-1505.
43. Sakai, N., Wada, T., Yokoyama, H., Lipp, M., Ueha, S., Matsushima, K., and Kaneko, S. (2006). Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc. Natl. Acad. Sci. U.S.A. 103, 14098-14103.
44. Sandbo, N., and Dulin, N. (2011). Actin cytoskeleton in myofibroblast differentiation: ultrastructure defining form and driving function. Transl. Res. 158, 181-196.
45. Scholten, D., Osterreicher, C. H., Scholten, A., Iwaisako, K., Gu, G., Brenner, D. A., and Kisseleva, T. (2010). Genetic labeling does not detect epithelial-to- mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 139, 987-998.
46. Schultz Jel, J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., and Doetschman, T. (2002). TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J. Clin. Invest. 109, 787-796.
47. Shim, Y. M., Zhu, Z., Zheng, T., Lee, C. G., Homer, R. J., Ma, B., and Elias, J. A. (2006). Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling. J. Immunol. 177, 1918-1924.
48. Simonian, P. L., Roark, C. L., Wehrmann, F., Lanham, A. K., Diaz del Valle, F., Born, W. K., O'Brien, R. L., and Fontenot, A. P. (2009). Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J. Immunol. 182, 657-665.
49. Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., and Neilson, E. G. (1995). Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130, 393-405.
50. Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., KarimiShah, B. A., Kim, N. D., Hart, W. K., Pardo, A., Blackwell, T. S., Xu, Y., Chun, J., and Luster, A. D. (2008). The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14, 45-54.
51. Takuwa, N., Ohkura, S., Takashima, S., Ohtani, K., Okamoto, Y., Tanaka, T., Hirano, K., Usui, S., Wang, F., Du, W., Yoshioka, K., Banno, Y., Sasaki, M., Ichi, I., Okamura, M., Sugimoto, N., Mizugishi, K., Nakanuma, Y., Ishii, I., Takamura, M., Kaneko, S., Kojo, S., Satouchi, K., Mitumori, K., Chun, J., and Takuwa, Y. (2010). S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc. Res. 85, 484-493.
52. Tanaka, M., Asada, M., Higashi, A. Y., Nakamura, J., Oguchi, A., Tomita, M., Yamada, S., Asada, N., Takase, M., Okuda, T., Kawachi, H., Economides, A. N., Robertson, E., Takahashi, S., Sakurai, T., Goldschmeding, R., Muso, E., Fukatsu, A., Kita, T., and Yanagita, M. (2010). Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J. Clin. Invest. 120, 768-777.
53. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
54. Thomas, P. E., Peters-Golden, M., White, E. S., Thannickal, V. J., and Moore, B. B. (2007). PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smadindependent but involves cell shape and adhesion-dependent signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L417-L428.
55. Venkov, C. D., Link, A. J., Jennings, J. L., Plieth, D., Inoue, T., Nagai, K., Xu, C., Dimitrova, Y. N., Rauscher, F. J., and Neilson, E. G. (2007). A proximal activator of transcription in epithelial-mesenchymal transition. J. Clin. Invest. 117, 482-491.
56. Visscher, D. W., and Myers, J. L. (2006). Histologic spectrum of idiopathic interstitial pneumonias. Proc. Am. Thorac. Soc. 3, 322-329.
57. Wells, R. G. (2010). The epithelialto-mesenchymal transition in liver fibrosis: here today, gone tomorrow? Hepatology 51, 737-740.
58. Witzgall, R., Brown, D., Schwarz, C., and Bonventre, J. V. (1994). Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J. Clin. Invest. 93, 2175-2188.
59. Wynn, T. A., and Barron, L. (2010). Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 30, 245-257.
60. Yin, Z., Tong, Y., Zhu, H., and Watsky, M. A. (2008). ClC-3 is required for LPA-activated Clcurrent activity and fibroblast-to-myofibroblast differentiation. Am. J. Physiol. Cell Physiol. 294, C535-C542.
61. Zeisberg, M., Hanai, J., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., and Kalluri, R. (2003). BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964-968.